Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas(Düsseldorf University Hospital), Michael Ghadimi(Universitätsmedizin Göttingen), Robert Grützmann(University Hospital Carl Gustav Carus), Claus Rödel(Goethe University Frankfurt), Jürgen Weitz(University Hospital Carl Gustav Carus), Günther Klautke(Klinikum Chemnitz), Gunnar Folprecht, Ludger Staib(Klinikum Esslingen), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lutz Jacobasch(Orthopädische Praxis), Bülent Polat(University of Würzburg), Wolf O. Bechstein(Unknown), Anca‐Ligia Grosu(University of Freiburg), Michael Flentje(Universitätsklinikum Würzburg), Ralf‐Dieter Hofheinz(University of Mannheim), Tim Friede(Universitätsmedizin Göttingen), Gerhard G. Grabenbauer(Klinikum Coburg), Thomas Kuhnt(Leipzig University), Matthias Schwarzbach(Klinikum Frankfurt Höchst), Thomas Brunner(Medical University of Graz), Wolff Schmiegel(Universitätsklinikum Knappschaftskrankenhaus Bochum), Michael Allgäuer(Heidelberg University), Christoph‐Thomas Germer(Universität Hamburg), Anke Schlenska‐Lange(Krankenhaus Barmherzige Brüder), Vittorio Paolucci(Sana Klinikum Offenbach)
Cited by 536
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k